BE862642A - Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine - Google Patents

Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine

Info

Publication number
BE862642A
BE862642A BE184108A BE184108A BE862642A BE 862642 A BE862642 A BE 862642A BE 184108 A BE184108 A BE 184108A BE 184108 A BE184108 A BE 184108A BE 862642 A BE862642 A BE 862642A
Authority
BE
Belgium
Prior art keywords
erythromycin
pharmaceutical preparation
preparation based
against infections
application against
Prior art date
Application number
BE184108A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BE862642A publication Critical patent/BE862642A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE184108A 1975-07-18 1978-01-04 Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine BE862642A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59705775A 1975-07-18 1975-07-18

Publications (1)

Publication Number Publication Date
BE862642A true BE862642A (fr) 1978-07-04

Family

ID=24389898

Family Applications (1)

Application Number Title Priority Date Filing Date
BE184108A BE862642A (fr) 1975-07-18 1978-01-04 Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine

Country Status (6)

Country Link
US (1) US4076804A (fr)
JP (1) JPS5486605A (fr)
AU (1) AU3172277A (fr)
BE (1) BE862642A (fr)
DE (1) DE2758942A1 (fr)
FR (1) FR2413090A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5118799A (en) * 1987-05-12 1992-06-02 Pharmacin Corporation Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
BE1002079A4 (fr) * 1988-07-01 1990-06-19 S M B Lab Composition pharmaceutique d'erythromycine a liberation prolongee, sa preparation et son utilisation.
IN192748B (fr) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
HUP0500791A2 (en) * 2001-08-29 2006-09-28 Ranbaxy Lab Ltd Controlled release formulation of clarithromycin or tinidazol
CN109846839B (zh) * 2019-01-31 2021-03-16 河北君临药业有限公司 一种琥乙红霉素颗粒及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
FR1258497A (fr) * 1959-04-30 1961-04-14 Wisconsin Alumni Res Found Procédé de granulation
US3084104A (en) * 1961-06-28 1963-04-02 Richardson Merrell Inc Process of preparing granulation of medicinal agents
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
FR2116M (fr) * 1962-02-05 1963-11-04 Vitamix Pharmaceuticals Compositions thérapeutiques a action prolongée pour l'administration orale de l'oxy-tétracycline.
FR1360432A (fr) * 1963-04-24 1964-05-08 Dairy Mour Procédé pour agglomérer des particules difficiles à agglomérer et produit obtenu
FR1503582A (fr) * 1966-07-18 1967-12-01 Sedaph Soc D Applic Pharma Sa Procédé de préparation d'une nouvelle forme solide de médicament
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
US3639168A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles
US3627583A (en) * 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles
NL164755C (nl) * 1969-09-01 1981-02-16 Meiji Seika Kaisha Werkwijze voor het bereiden van gemakkelijk oplosbare en/of dispergeerbare korrels.
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
US3878192A (en) * 1972-06-05 1975-04-15 Blasina Lab Chim Farm Sweet and palatable water soluble derivatives of erythromycin
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
JPS5418330B2 (fr) * 1973-03-16 1979-07-06
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition

Also Published As

Publication number Publication date
US4076804A (en) 1978-02-28
DE2758942A1 (de) 1979-07-05
JPS5486605A (en) 1979-07-10
AU3172277A (en) 1979-06-28
FR2413090A1 (fr) 1979-07-27

Similar Documents

Publication Publication Date Title
AR213619A1 (es) Polimero de ortoester y su preparacion
BE867046A (fr) Nouveaux (halo-alcoxy-phenyl-amino)-carbonyl-benzamides insecticides et leurs preparation
BE871584A (fr) Preparations pharmaceutiques
BE844363A (fr) Capsules et compositions de conditionnement de tissus
BE862642A (fr) Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine
FR2347933A1 (fr) Vaccin antirabique et son procede de preparation
DK194776A (da) Antibakterielle midler og mellemprodukter dertil
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
BE879471A (fr) Solution stable d'erythromycine
BE839947A (fr) Nouveaux antibiotiques d'aminoglycoside
NL7510259A (nl) Uridinederivaat alsmede farmaceutisch preparaat.
BE843195A (fr) Nouvel agent antidiabetique et derives d'isoxazole
FR2318973A1 (fr) Capsules et compositions de conditionnement de tissus
SE7609908L (sv) 1,5-dihydro-2h-1,4-bensodiazepin-2-on-derivat och framstellning derav
FR2330408A1 (fr) Agent antihemophilique et son procede de preparation
SE7607241L (sv) Aralifatiska dihalogenforeningar och forfarande for framstellning derav
NL176174C (nl) Derivaten van erythromycine a en werkwijze voor de bereiding daarvan.
SE7610561L (sv) Halogenerade alkoxisilanforeningar och forfarande for deras framstellning
FR2307820A1 (fr) Glycosides d'echinatine et leur preparation
BE853569A (nl) Medicinale preparaten
SE7705857L (sv) Farmaceutiskt aktiva foreningar
NL930050I1 (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten
FR2317920A1 (fr) Preparations anthelmintiques
SE7604524L (sv) Spolhanteringsanordning och system
BE851509A (fr) Derives de piperidine et leur preparation